SCHEMBL13314643

SCHEMBL13314643

Nc1cccc(NC(=O)CN2CCN(CC3CC3)CC2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
POLB P06746 1/20 0.57
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2C9 P11712 1/20 0.52
DRD4 P21917 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
DRD2 P14416 2/20 0.51
DRD3 P35462 2/20 0.51
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
CYP1A2 P05177 1/20 0.49
RECQL P46063 1/20 0.49
HTT P42858 1/20 0.49
KCNT1 Q5JUK3 2/20 0.48
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3221943 0.85 POLB (0.78) ALDH1A1POLBCYP2D6CYP2C19SMN1; SMN2
SCHEMBL13314890 0.85 POLB (0.57) ALDH1A1POLBCYP2D6CYP2C19CYP2C9
SCHEMBL13460020 0.84 POLB (0.59) ALDH1A1POLBCYP2D6CYP2C19CYP2C9
SCHEMBL4504352 0.84 ALDH1A1 (0.64) ALDH1A1POLBCYP2C19DRD4SMN1; SMN2
SCHEMBL3220294 0.84 POLB (0.81) ALDH1A1POLBCYP2D6CYP2C19SMN1; SMN2
SCHEMBL13314913 0.83 SMN1; SMN2 (0.72) ALDH1A1POLBCYP2D6CYP2C19CYP2C9
SCHEMBL13459926 0.82 ALDH1A1 (0.61) ALDH1A1POLBDRD4SMN1; SMN2DRD2
SCHEMBL3203453 0.82 ALDH1A1 (0.72) ALDH1A1POLBSMN1; SMN2LMNAHTT
SCHEMBL4578859 0.81 ALDH1A1 (0.67) ALDH1A1POLBDRD4SMN1; SMN2DRD2
Hydrochloric Acid SCHEMBL4576674 0.80 ALDH1A1 (0.66) ALDH1A1POLBDRD4SMN1; SMN2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737157-B2 Pyrimidine compounds HUTCHISON MEDIPHARMA ENTERPRISES LIMITED (BS) 2010-06-15 US disclosed
WO-2010025138-A2 PYRIMIDINE COMPOUNDS HUTCHISON MEDIPHARMA ENTERPRISES LIMITED (BS) 2010-03-04 WO disclosed
US-20100056512-A1 PYRIMIDINE COMPOUNDS HUTCHISON MEDIPHARMA ENTERPRISES LIMITED (BS) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056512-A1 PYRIMIDINE COMPOUNDS TYMS, TYMP, DPYD ALDH1A1 772/4885POLB 134/4885CYP2D6 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.